In the News

Breast cancer affects one in eight women in the United States, with approximately 70 to 80 percent of employed breast cancer survivors returning to work three to eighteen months following diagnosis. Job loss can have devastating financial consequences, including increased risk of bankruptcy and debt. Victoria Blinder, MD, medical oncologist at Memorial Sloan Kettering, conducted a longitudinal study of a racially and ethnically diverse sample of employed women undergoing treatment for stage I-III breast cancer in New York City. For more information on this study, published in <i>Health Affairs</i> on February 6, 2017, and to speak with the study author, contact [email protected].

Read a Q & A with Lucy Kalanithi, the widow of Paul Kalanithi, who wrote When Breath Becomes Air.

Learn about a potential new strategy for treating people with blood cancers such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) that targets a protein on cancer stem cells.

Discover the significance of the Josie Robertson Surgery Center’s signature art piece.

Learn why some patients are less physically active during and after treatment — plus, some tips from Jun Mao, Chief of the Integrative Medicine Service at MSK.

Using stem cells, scientists can create batches of cortical neurons to study schizophrenia and autism.

New research of metastatic pancreatic cancer has shown that the same mutations are involved in driving both the primary tumor and the metastases.

MSK now offers interventional radiology consultations as well as many procedures at three of its outpatient locations.

A study reveals unexpected insights into how cells prepare broken DNA strands to be rejoined, preventing mutations that can cause cancer.

Eight leading cancer centers are coming together to share genomic sequencing data, in the hope of making faster progress in curing cancer.